Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Stem cell niches support, regulate, and coordinate stem cell functions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Ducks can get the Rous sarcoma virus if infected shortly after birth, leading to tumors and disease spread.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

PLD is an effective and safer alternative for treating breast cancer.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The HOXC13 gene affects different hair proteins in cashmere goats in varied ways and is controlled by a feedback loop and other factors.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.